ERS Genomics is rated 3 out of 5 in the category biotechnology. Read and write reviews about ERS Genomics. ERS Genomics was formed to commercialise the foundational CRISPR-Cas9 intellectual property held by co-inventor and co-owner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use. CRISPR-Cas9 is a revolutionary new genome editing technology, which offers significant advantages in speed, efficiency and cost over earlier genome editing methods.
Address
ERS Genomics Limited 88 Harcourt Street
Company size
1-10 employees